We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Heart Valve Incorporates Tissue Treatment

By HospiMedica staff writers
Posted on 08 Feb 2005
A new treatment process incorporated into tissue heart valves significantly reduces leaflet calcification, one of the primary causes of tissue valve deterioration.

The process, called ThermaFix, was co-developed by biochemist Sophie Carpentier, Ph.D., and her husband, Prof. More...
Alain Carpentier, chairman of the department of cardiovascular surgery at the Hopital Europeen Georges Pompidou in Paris (France). The ThermaFix process is now available on all the Perimount Magna replacement tissue heart valves of Edwards Life Sciences (Irvine, CA, USA).

The Perimount Magna valve, an aortic replacement tissue heart valve constructed of bovine pericardium, is designed specifically to optimize blood flow. It facilitates placement above the patient's native valve opening, which may allow surgeons to implant a valve that is larger than other conventional tissue valves. Surgeons generally prefer valves that can provide optimal blood flow for their patients, and the Perimount valve line has been shown to provide greater valve opening areas to facilitate blood flow, according to an article in the September 2004 issue of Circulation.

"Although pericardial valves have demonstrated decades of reliable performance, mitigating the calcification of a tissue valve's leaflets has been a focus of research and development since their introduction,” noted Albert Starr, M.D., medical director of the Providence Heart and Vascular Institute (Oregon). "By coupling the Perimount Magna valve's improved hemodynamic performance with the ThermaFix process, Edwards is providing patients with the confidence that they are getting the best technology there is to offer.”





Related Links:
Edwards Life Sciences
Providence Heart & Vascular

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hybrid Arch Device
Neo EDE
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.